334 related articles for article (PubMed ID: 19910347)
1. Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005.
Lillie-Blanton M; Stone VE; Snow Jones A; Levi J; Golub ET; Cohen MH; Hessol NA; Wilson TE
Am J Public Health; 2010 Aug; 100(8):1493-9. PubMed ID: 19910347
[TBL] [Abstract][Full Text] [Related]
2. Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity.
McFall AM; Dowdy DW; Zelaya CE; Murphy K; Wilson TE; Young MA; Gandhi M; Cohen MH; Golub ET; Althoff KN;
J Acquir Immune Defic Syndr; 2013 Nov; 64(3):289-98. PubMed ID: 23797695
[TBL] [Abstract][Full Text] [Related]
3. Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S.
Kahn JG; Zhang X; Cross LT; Palacio H; Birkhead GS; Morin SF
Public Health Rep; 2002; 117(3):252-62; discussion 231-2. PubMed ID: 12432136
[TBL] [Abstract][Full Text] [Related]
4. Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States.
Beer L; Mattson CL; Bradley H; Skarbinski J;
Medicine (Baltimore); 2016 Mar; 95(13):e3171. PubMed ID: 27043679
[TBL] [Abstract][Full Text] [Related]
5. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
[TBL] [Abstract][Full Text] [Related]
6. Race and insurance status as risk factors for trauma mortality.
Haider AH; Chang DC; Efron DT; Haut ER; Crandall M; Cornwell EE
Arch Surg; 2008 Oct; 143(10):945-9. PubMed ID: 18936372
[TBL] [Abstract][Full Text] [Related]
7. Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth.
Yee LM; Liu LY; Sakowicz A; Bolden JR; Miller ES
Am J Obstet Gynecol; 2016 Mar; 214(3):374.e1-6. PubMed ID: 26829989
[TBL] [Abstract][Full Text] [Related]
8. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.
Gebo KA; Fleishman JA; Conviser R; Reilly ED; Korthuis PT; Moore RD; Hellinger J; Keiser P; Rubin HR; Crane L; Hellinger FJ; Mathews WC;
J Acquir Immune Defic Syndr; 2005 Jan; 38(1):96-103. PubMed ID: 15608532
[TBL] [Abstract][Full Text] [Related]
9. Association of medical insurance and other factors with receipt of antiretroviral therapy.
Keruly JC; Conviser R; Moore RD
Am J Public Health; 2002 May; 92(5):852-7. PubMed ID: 11988459
[TBL] [Abstract][Full Text] [Related]
10. Annual report on health care for children and youth in the United States: trends in racial/ethnic, income, and insurance disparities over time, 2002-2009.
Berdahl TA; Friedman BS; McCormick MC; Simpson L
Acad Pediatr; 2013; 13(3):191-203. PubMed ID: 23680339
[TBL] [Abstract][Full Text] [Related]
11. Racial and Ethnic Disparities Among the Remaining Uninsured Young Adults with Behavioral Health Disorders After the ACA Expansion of Dependent Coverage.
Novak P; Williams-Parry KF; Chen J
J Racial Ethn Health Disparities; 2017 Aug; 4(4):607-614. PubMed ID: 27450047
[TBL] [Abstract][Full Text] [Related]
12. Effect of dysthymia on receipt of HAART by minority HIV-infected women.
Turner BJ; Fleishman JA
J Gen Intern Med; 2006 Dec; 21(12):1235-41. PubMed ID: 17105522
[TBL] [Abstract][Full Text] [Related]
13. Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009.
Ludema C; Cole SR; Eron JJ; Edmonds A; Holmes GM; Anastos K; Cocohoba J; Cohen M; Cooper HL; Golub ET; Kassaye S; Konkle-Parker D; Metsch L; Milam J; Wilson TE; Adimora AA
J Acquir Immune Defic Syndr; 2016 Nov; 73(3):307-312. PubMed ID: 27763995
[TBL] [Abstract][Full Text] [Related]
14. The potential for elimination of racial-ethnic disparities in HIV treatment initiation in the Medicaid population among 14 southern states.
Zhang S; McGoy SL; Dawes D; Fransua M; Rust G; Satcher D
PLoS One; 2014; 9(4):e96148. PubMed ID: 24769625
[TBL] [Abstract][Full Text] [Related]
15. Racial, gender and geographic disparities of antiretroviral treatment among US Medicaid enrolees in 1998.
King WD; Minor P; Ramirez Kitchen C; Oré LE; Shoptaw S; Victorianne GD; Rust G
J Epidemiol Community Health; 2008 Sep; 62(9):798-803. PubMed ID: 18701730
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization.
Cunningham WE; Markson LE; Andersen RM; Crystal SH; Fleishman JA; Golin C; Gifford A; Liu HH; Nakazono TT; Morton S; Bozzette SA; Shapiro MF; Wenger NS
J Acquir Immune Defic Syndr; 2000 Oct; 25(2):115-23. PubMed ID: 11103041
[TBL] [Abstract][Full Text] [Related]
17. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Ettner SL;
J Acquir Immune Defic Syndr; 2008 Apr; 47(4):449-58. PubMed ID: 18197121
[TBL] [Abstract][Full Text] [Related]
18. Geographical distribution of surgical capabilities and disparities in the use of high-volume providers: the case of coronary artery bypass graft.
Bao Y; Kamble S
Med Care; 2009 Jul; 47(7):794-802. PubMed ID: 19536028
[TBL] [Abstract][Full Text] [Related]
19. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States.
Dale S; Cohen M; Weber K; Cruise R; Kelso G; Brody L
AIDS Patient Care STDS; 2014 Mar; 28(3):136-43. PubMed ID: 24568654
[TBL] [Abstract][Full Text] [Related]
20. African-American patients are less likely to receive drug-eluting stents during percutaneous coronary intervention.
Gaglia MA; Shavelle DM; Tun H; Bhatt J; Mehra A; Matthews RV; Clavijo L
Cardiovasc Revasc Med; 2014 Jun; 15(4):214-8. PubMed ID: 24814420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
